Found 10 results

Name Type of Offering Accepted Date
Paragon Biosciences Emalex Capital, Inc.
D/A 2021-03-12 13:51:38
Amount To Be Raised $35,000,010
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-21-000002
Exclusions or Exemptions 506b
Accepted Date 2021-03-12 13:51:38
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D 2019-10-03 17:29:31
Amount To Be Raised $37,423,356
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-19-000001
Exclusions or Exemptions 506b
Accepted Date 2019-10-03 17:29:31
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D 2022-11-04 12:31:48
Amount To Be Raised $250,000,000
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-22-000002
Exclusions or Exemptions 506b
Accepted Date 2022-11-04 12:31:48
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D 2018-08-14 11:07:07
Amount To Be Raised $6,925,000
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-18-000002
Exclusions or Exemptions 506b
Accepted Date 2018-08-14 11:07:07
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D/A 2025-07-08 17:28:14
Amount To Be Raised $270,000,000
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-25-000003
Exclusions or Exemptions 506b
Accepted Date 2025-07-08 17:28:14
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D 2021-03-12 11:02:02
Amount To Be Raised $35,000,010
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-21-000001
Exclusions or Exemptions 506b
Accepted Date 2021-03-12 11:02:02
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D 2022-11-04 11:58:08
Amount To Be Raised $25,000,000
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-22-000001
Exclusions or Exemptions 506b
Accepted Date 2022-11-04 11:58:08
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Debt
Paragon Biosciences Emalex Capital, Inc.
D/A 2022-11-09 17:36:09
Amount To Be Raised $250,000,000
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-22-000003
Exclusions or Exemptions 506b
Accepted Date 2022-11-09 17:36:09
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D/A 2018-12-06 17:37:06
Amount To Be Raised $9,375,000
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-18-000003
Exclusions or Exemptions 506b
Accepted Date 2018-12-06 17:37:06
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity
Paragon Biosciences Emalex Capital, Inc.
D/A 2025-03-25 11:04:05
Amount To Be Raised $242,000,000
Associated Brokers / Dealers N/A
CIK Number 0001749990
Filed Document 0001749990-25-000002
Exclusions or Exemptions 506b
Accepted Date 2025-03-25 11:04:05
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business ILLINOIS
Revenue or Assets Decline to Disclose
Type of Security Equity